Effect of (-)-trans-PAT, a novel 5-HT2C receptor agonist, on intake of palatable food in mice

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 1, 2008, Pages 176-180

  Rowland, Neil E ^a   Crump, Erica M ^a   Nguyen, Nancy ^a   Robertson, Kimberly ^a   Sun, Zhuming ^a   Booth, Raymond G ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Amphetamine; Dose effect curve; Food intake; Isobologram; Serotonin type 2C receptor; Tolerance; WAY 161503

Indexed keywords

1 PHENYL 3 DIMETHYLAMINO 1,2,3,4 TETRAHYDRONAPHTHALENE; 8,9 DICHLORO 2,3,4,4A TETRAHYDRO 1H PYRAZINO[1,2 A]QUINAZOLIN 5(6H) ONE; AMPHETAMINE; NAPHTHALENE DERIVATIVE; SEROTONIN 2C AGONIST; SEROTONIN 2C RECEPTOR; TETRAHYDROQUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; WAY 161503;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG TOLERANCE; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMPHETAMINE; ANIMALS; APPETITE DEPRESSANTS; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG TOLERANCE; EATING; FEMALE; FOOD PREFERENCES; MICE; MICE, INBRED C57BL; PYRAZINES; QUINOXALINES; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN AGONISTS; TETRAHYDRONAPHTHALENES;

MUS;

EID: 50349084642     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.07.004     Document Type: Article

References (32)

1. Bivens N.M., Weisstuab N.V., Bradley-Moore M., Kumar K., Booth R.G., and Gingrich J.A. (-)-trans-PAT: a novel 5HT2C receptor agonist/5HT2A receptor antagonist exhibits antipsychotic and appetite suppressant properties. American College of Neuropsychopharmacology 46th Annual Meeting, Boca Raton, Fl, December 9-13 (2007)
2. 2A/2B receptor antagonist and inverse agonist activity. (Submitted to Eur J Pharmacol) 2008.
3. Bromidge S.M., Duckworth M., Forbes I.T., Ham P., King F.D., Thewlis K.M., et al. 6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist. J Med Chem 40 (1997) 3494-3496
4. Connolly H.M., Crary J.L., McGoon M.D., Hensrud D.D., Edwards B.S., Edwards W.D., et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337 (1997) 581-588 (Erratum in: N. Engl. J. Med. 1997, 337, 1783)
5. Fitzgerald L.W., Burn T.C., Brown B.S., Patterson J.P., Corjay M.H., Valentine P.A., et al. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57 (2000) 75-81
6. Halford J.C., Harrold J.A., Boyland E.J., Lawton C.L., and Blundell J.E. Serotonergic drugs: effects on appetite suppression and use for the treatment of obesity. Drugs 67 (2007) 27-55
7. Heisler L.K., Cowley M.A., Tecott L.H., Fan W., Low M.J., Smart J.L., et al. Activation of central melanocortin pathways by fenfluramine. Science 297 (2002) 609-611
8. Julius D., Huang K.N., Livelli T.J., Axel R., and Jessel T.M. The 5-HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc Natl Acad Sci 87 (1990) 928-932
9. Knight A.R., Misra A., Quirk K., Benwell K., Revell D., Kennett G., et al. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn-Schmiedeberg's Arch Pharmacol 370 (2004) 114-123
10. Launay J.M., Herve P., Peoc'h K., Tournois C., Callebert J., Nebigil C.G., et al. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8 (2002) 1129-1135
11. Nichols D.E. Hallucinogens. Pharmacol Ther 101 (2004) 131-181
12. Nilsson B.M. 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents. J Med Chem 49 (2006) 4023-4034
13. Pouwels H.M., Smeets J.L., Cheriex E.C., and Wouters E.F. Pulmonary hypertension and fenfluramine. Eur Respir J 3 (1990) 606-607
14. Raymond J.R., Mukhin Y.V., Gelasco A., Turner J., Collinsworth G., Gettys T.W., et al. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92 (2001) 179-212
15. Richter H.G., Adams D.R., Benardeau A., Bickerdike M.J., Bentley J.M., Blench T.J., et al. Synthesis and biological evaluation of novel hexahydro-pyrido[3¢,2¢:4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT(2C) receptor agonists. Bioorg Med Chem Lett 16 (2006) 1207-1211
16. Robertson K.L., and Rowland N.E. Effect of two types of environmental enrichment for singly housed mice on food intake and weight gain. Lab Anim. 34 (2005) 29-32
17. 2C receptor agonist WAY-161503. Brain Res 1073 (2006) 240-251
18. Roth B.L. Drugs and valvular heart disease. N Engl J Med 356 (2007)
19. Roth J.D., and Rowland N.E. Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?. Eur J Pharmacol 373 (1999) 127-134
20. Rothman R.B., Baumann M.H., Savage J.E., Rauser L., McBride A., Hufeisen S.J., et al. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102 (2000) 2836-2841
21. Rowland N.E., and Carlton J. Inhibition of gastric emptying by peripheral and central fenfluramine in rats: correlation with anorexia. Life Sci 34 (1984) 2495-2499
22. Rowland N.E., Lo J., and Robertson K. Acute anorectic effect of single and combined drugs in mice using a non-deprivation protocol. Psychopharmacology 157 (2001) 193-196
23. Sanders-Bush E., and Mayer S.E. Serotonin receptor agonists and antagonists. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics. 11th Edition (2006), McGraw-Hill, New York, NY 297-315
24. 1C receptor subtypes. Biochem Biophys Res Commun 181 (1991) 1469-7148
25. 2B receptor. Mol Pharmacol 68 (2005) 20-33
26. Siuciak J.A., Chapin D.S., McCarthy S.A., Guanowsky V., Brown J., Chiang P., et al. CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity. Neuropharmacology 52 (2007) 279-290
27. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374 (1995) 542-546
28. 2C receptors. Neuropharmacology 41 (2001) 200-209
29. 2C receptor mutant mice. Psychopharmacology 143 (1999) 309-314
30. Wacker D.A., Varnes J.G., Malmstrom S.E., Cao X., Hung C.P., Ung T., et al. Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptor. J Med Chem 50 (2007) 1365-1379
31. Weintraub M., Sundaresan P.R., Schuster B., Moscucci M., and Stein E.C. Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine. Clin Pharmacol Ther 51 (1992) 602-607
32. Wyrick S.D., Booth R.G., Myers A.M., Owens C.E., Kula N.S., Baldessarini R.J., et al. Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity. J Med Chem 36 (1993) 2542-2551